GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
A study on visual language models explores how shared semantic frameworks improve image–text understanding across ...
Cantargia AB (Publ) (Nasdaq Stockholm:CANTA) today reported that the rationale and study design of the phase 1b/2 clinical trial investigating nadunolimab in combination with immune-checkpoint ...
OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company ...
AI factories are pushing data center power and cooling requirements beyond traditional limits, making integrated AI data ...
AGIBOT, a global leading robotics company specializing in embodied intelligence, today announced a new generation of embodied ...
Stanford's 2026 AI Index covers 400+ pages of data. Here's what search professionals should take from the adoption numbers, ...
Backed by Prosperity7 Ventures, the "super agent" startup — has raised $25M in under a year and hit 200,000 users by turning ...
Manycore Tech debuts on Hong Kong's stock exchange today, following a $130 million IPO—and contributing to the Chinese city's ...
For companies, this creates both urgency and opportunity: organisations that adopt AI will have better audit defences, faster ...
Think only Japanese engines are reliable? These 10 powerplants from BMW, GM, Ford and others prove there are excellent ...
With thousands of treatments and years of clinical operations behind it, Beond arrives at the center of America's most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results